Trials / Completed
CompletedNCT00345202
Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Regional Hospital Holstebro · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
We wanted to test the shortterm effects of HMG-CoA reductase inhibition (atorvastatin) on renal hemodynamics, renal tubular function and vasoactive hormones on healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HMG-CoA reductase inhibition (atorvastatin) |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2005-02-01
- Completion
- 2005-02-01
- First posted
- 2006-06-27
- Last updated
- 2008-05-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00345202. Inclusion in this directory is not an endorsement.